SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ORIC Pharmaceuticals Q3 net loss widens 48% to $48.08 million

ORIC Pharmaceuticals Q3 net loss widens 48% to $48.08 million ORIC Pharmaceuticals’ third-quarte

ORIC

Related stories